WEKO3
アイテム
{"_buckets": {"deposit": "25426f39-97db-44b1-8f32-a2591a600696"}, "_deposit": {"created_by": 2, "id": "2181", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "2181"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00002181", "sets": ["30"]}, "author_link": ["10198", "10196", "10199", "10197", "10202", "10205", "10201", "10200", "10203", "10204", "10206"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-01-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "83", "bibliographicPageStart": "79", "bibliographicVolumeNumber": "56", "bibliographic_titles": [{"bibliographic_title": "Internal Medicine"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated with pazopanib, a multikinase inhibitor, drug-induced interstitial lung disease (DILD) has not been reported. A 74-year-old Japanese man who received pazopanib for the treatment of femoral leiomyosarcoma and lung metastasis presented with dyspnea and fatigue. He had mild interstitial pneumonia when pazopanib treatment was initiated. Chest computed tomography revealed progressive bilateral ground-glass opacity (GGO) and traction bronchiectasis. We diagnosed DILD due to pazopanib. The patient’s pazopanib treatment was interrupted and a steroid was administered. The symptoms and GGO were improved with treatment. Physicians should be aware of DILD due to pazopanib in patients with pre-existing interstitial lung disease.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Internal Medicine, 56(1), pp.79-83; 2017", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本内科学会"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.56.7380", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2017 The Japanese Society of Internal Medicine"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "09182918", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "13497235", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "Japanese Society of Internal Medicine"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Ide, Shotaro"}], "nameIdentifiers": [{"nameIdentifier": "10196", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakamoto, Noriho"}], "nameIdentifiers": [{"nameIdentifier": "10197", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hara, Shintaro"}], "nameIdentifiers": [{"nameIdentifier": "10198", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hara, Atsuko"}], "nameIdentifiers": [{"nameIdentifier": "10199", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kakugawa, Tomoyuki"}], "nameIdentifiers": [{"nameIdentifier": "10200", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakamura, Yoichi"}], "nameIdentifiers": [{"nameIdentifier": "10201", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Futsuki, Yoji"}], "nameIdentifiers": [{"nameIdentifier": "10202", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumikawa, Koichi"}], "nameIdentifiers": [{"nameIdentifier": "10203", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishimatsu, Yuji"}], "nameIdentifiers": [{"nameIdentifier": "10204", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yanagihara, Katsunori"}], "nameIdentifiers": [{"nameIdentifier": "10205", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mukae, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "10206", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-21"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "IntMed56_79.pdf", "filesize": [{"value": "2.2 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 2200000.0, "url": {"label": "IntMed56_79.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/2181/files/IntMed56_79.pdf"}, "version_id": "c69b57b9-fd9e-406e-a30c-4556e6c65469"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Drug-induced interstitial lung disease", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Interstitial pneumonia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Molecular target drug", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Pazopanib", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Pneumonitis", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Interstitial Lung Disease Induced by Pazopanib Treatment", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Interstitial Lung Disease Induced by Pazopanib Treatment"}]}, "item_type_id": "2", "owner": "2", "path": ["30"], "permalink_uri": "http://hdl.handle.net/10069/37379", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-30"}, "publish_date": "2017-05-30", "publish_status": "0", "recid": "2181", "relation": {}, "relation_version_is_last": true, "title": ["Interstitial Lung Disease Induced by Pazopanib Treatment"], "weko_shared_id": -1}
Interstitial Lung Disease Induced by Pazopanib Treatment
http://hdl.handle.net/10069/37379
http://hdl.handle.net/10069/373790a93966d-581f-48e9-9ea8-69390aec193c
名前 / ファイル | ライセンス | アクション |
---|---|---|
IntMed56_79.pdf (2.2 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-05-30 | |||||
タイトル | ||||||
タイトル | Interstitial Lung Disease Induced by Pazopanib Treatment | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Drug-induced interstitial lung disease | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Interstitial pneumonia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Molecular target drug | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Pazopanib | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Pneumonitis | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Ide, Shotaro
× Ide, Shotaro× Sakamoto, Noriho× Hara, Shintaro× Hara, Atsuko× Kakugawa, Tomoyuki× Nakamura, Yoichi× Futsuki, Yoji× Izumikawa, Koichi× Ishimatsu, Yuji× Yanagihara, Katsunori× Mukae, Hiroshi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated with pazopanib, a multikinase inhibitor, drug-induced interstitial lung disease (DILD) has not been reported. A 74-year-old Japanese man who received pazopanib for the treatment of femoral leiomyosarcoma and lung metastasis presented with dyspnea and fatigue. He had mild interstitial pneumonia when pazopanib treatment was initiated. Chest computed tomography revealed progressive bilateral ground-glass opacity (GGO) and traction bronchiectasis. We diagnosed DILD due to pazopanib. The patient’s pazopanib treatment was interrupted and a steroid was administered. The symptoms and GGO were improved with treatment. Physicians should be aware of DILD due to pazopanib in patients with pre-existing interstitial lung disease. | |||||
書誌情報 |
Internal Medicine 巻 56, 号 1, p. 79-83, 発行日 2017-01-01 |
|||||
出版者 | ||||||
出版者 | 日本内科学会 | |||||
出版者別言語 | ||||||
Japanese Society of Internal Medicine | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 09182918 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 13497235 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.56.7380 | |||||
権利 | ||||||
権利情報 | c 2017 The Japanese Society of Internal Medicine | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Internal Medicine, 56(1), pp.79-83; 2017 |